Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 27,762 shares at $101.46 ($2.8M) on 2018-04-16, disclosed to the SEC on 2018-04-18.
Open-market sale of $2.8M NKTR by SVP & Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.46 | 13,881 | $1.4M | 50.0% |
| 2 | $101.46 | 13,881 | $1.4M | 50.0% |
| Total | $101.46 avg | 27,762 | $2.8M | 100% |
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |